CRP and neoplasm: The assumed mechanism underlying these correlations are as follows: (1) A substantial tumor burden, such as greater tumor volume and nodal metastasis, may occur along with high cancer-related systemic inflammation, thus possibly increasing CRP (50) and interleukin (33) levels and thereby engendering a high HS-mGPS (2).